Anti-apoptotic function of propargylamine inhibitors of type-B monoamine oxidase

被引:32
作者
M. Naoi
W. Maruyama
M. B. H. Youdim
P. Yu
A. A. Boulton
机构
[1] Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park, Gifu 505-0116, Mitake, Kani-gun
[2] Department of Basic Gerontology, Natl. Inst. for Longevity Sciences, Obu
[3] Technion-Israel Inst. of Technology, Faculty of Medicine, Eve Topf/NPF Ctrs. E. N. D. R., Haifa
[4] Department of Psychiatry, University of Saskatchewan, Saskatoon, Sask.
关键词
Mitochondrial Membrane; Neurodegenerative Disease; Neurodegenerative Disorder; Mitochondrial Membrane Potential; Monoamine Oxidase;
D O I
10.1163/156856003765764344
中图分类号
学科分类号
摘要
In Parkinson's disease and other neurodegenerative diseases, (-)deprenyl, an inhibitor of type B monoamine oxidase (MAO-B), has been proposed to protect or rescue declining neurons. However, clinical trials failed to confirm the neuroprotection, even though in vivo and in vitro studies suggested the possibilities. This paper describes the activities of propargylamine MAO-B inhibitors against apoptosis induced by an endogenous selective dopaminergic neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells. A series of propargylamines were shown to suppress the apoptotic cascade; preventing collapse of mitochondrial membrane potential, activation of caspase 3 and fragmentation of nucleosomal DNA. Among propargylamines, (R)-N-propargyl1-aminoindan (rasagiline) was the most potent at preventing cell death. Rasagiline also prevented opening of permeability transition pore in insolated mitochondria. These results suggest that rasagiline and other propargylamines may regulate the apoptotic machinery in mitochondria and rescue or protect deteriorated neurons in neurodegenerative disorders.
引用
收藏
页码:175 / 181
页数:6
相关论文
共 22 条
[1]  
Akao Y., Nakagawa Y., Maruyama W., Takahashi T., Naoi M., Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, is mediated by activation of caspase 3, Neurosci. Lett., 267, pp. 153-156, (1999)
[2]  
Akao Y., Maruyama W., Shimizu S., Yi H., Et al., Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan, J. Neurochem., 82, pp. 913-923, (2002)
[3]  
Biangini G., Frasoldati A., Fuxe K., Agnati L.F., Et al., L-deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brain, NeuroReport, 4, pp. 955-958, (1993)
[4]  
Birkmayer W., Riederer P., Youdim M.B.H., Linauet W., Et al., The potentiation of the anti-akinetic effect of L-dopa treatment by an inhibitor of MAO-B, L-deprenyl, J. Neural Transm., 30, pp. 303-336, (1975)
[5]  
Bronzetti E., Felici L., Ferrante F., Vasecchi B., Et al., Effect of ethylcholine mustard aziridinium (AF64A) and on monoamine oxidase-B-inhibitor L-deprenyl on the morphology of rat hippocampus, Int. J. Tissue React., 14, pp. 175-182, (1992)
[6]  
Dipasquale B., Marini A.M., Youle R.J., Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons, Biochem. Biophys. Res. Commun., 181, pp. 1442-1448, (1991)
[7]  
Maruyama W., Naoi M., Kasamatsu T., Et al., An endogenous dopaminergic neurotoxin, N-methyl-(R)salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells, J. Neurochem., 69, pp. 322-329, (1997)
[8]  
Maruyama W., Takahashi T., Naoi M., (-)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide, J. Neurochem., 70, pp. 2510-2515, (1998)
[9]  
Maruyama W., Boulton A.A., Davis B.A., Et al., Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: Suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine, J. Neural Trans., 108, pp. 11-24, (2001)
[10]  
Maruyama W., Takahashi T., Youdim Y., Et al., The anti-parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells, J. Neural. Transm., 109, pp. 467-481, (2002)